Tapinarof Under FDA Review for Treating Atopic Dermatitis

Approved in 2022 for psoriasis, the manufacturer has submitted an application for approval of tapinarof cream for treating atopic dermatitis in adults and children 2 years of age and older.
MDedge News

source https://www.medscape.com/s/viewarticle/topical-tapinarof-under-fda-review-new-indication-atopic-2024a100039i?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?